A Randomized Controlled Clinical Trial to evaluate the effect of Vachaharidradi Ghana Vati in the management of Dyslipidemia
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Reduction in Lipid Profile
研究概览
简要总结
Dyslipidemia is manifested by the elevation of total cholestrol low density lipoprotein cholestrol triglycerides and a decrease in the high density lipoprotein cholestrol
Dyslipidemia has no specific signs and symptoms
In Ayurveda the concept of Dyslipidemia goes in parallel with Medorogam. Ati Santarpana leads to Kapha Vriddhi;
Dushti of Rasa and Medo Dhathu. Medorogam occurs due to Medo Dhathu Dushti which
causes Medo Dhathvagni Mandhyam. The treatment should aim at Apatarpana, Ama
Pachana, Srotoshodhana and Kapha Medohara Chikitsa which helps in attaining Samyata of
Dosha and Dushya. VachaHaridradi Gana contains Vacha, Musta, Devadaru, Nagara,
Ativisha, Haritaki, Haridra, Daruharidra, Yashtimadhu, Prishniparni and Kutaja. It is Katu,
Tikta Rasayuktha. Due to Laghu Ruksha Guna, it does Medoshoshana; it is Ushna in Virya
and Katu in Vipaka and Kapha Medahara in nature. It is Pachana, Deepanam, Kleda-Meda
Shoshaka, Srotovishodaka and Lekhana in nature. It is found that drugs like Vacha, Musta
and Ativisha have hypolipidemic properties.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 64.00 Year(s)(—)
- 性别
- All
入选标准
- •subjects between age of 18 to 64 years of age.
- •Patients Fulfilling the diagnostic and pre diagnosed patients with dyslipidemic range total cholestrol 200 to 239 mg per dl LDL 129 to 159 mg per dl Triglyceride 150 to 199 mg per dl HDL less than 40 mg per dl QRISK Value less than 10 percentage.
排除标准
- •known case of primary dyslipidemia, coronary artery disease, cerebrovascular accident, peripheral artery disease carcinomas renal disorders like chronic kidney disease and nephrotic syndrome hepatic disorders like liver cirrhosis, steatotic liver disease, hypothyroidism, hypertension, diabetes mellitus Dyslipidemia due to consumption of drugs like glucocorticoids and diuretics pregnant and lactating women.
结局指标
主要结局
Reduction in Lipid Profile
时间窗: 31 days
次要结局
未报告次要终点
研究者
Dr K R Sreeranjani
Sri Jayendra Saraswathi Ayurveda College and Hospital
